The new Alzheimer drug, Aduhelm Coverage, to be limited
According to Medicare officials, The Federal Health Insurance Program will restrict the coverage of Aduhelm, the new Alzheimer’s drug, to only patients who are participating in the randomized controlled clinical trials. The final decision is set to take place by April 11. The drug, Aduhelm, is the first treatment to be approved for the treatment … Read more
